GI & Endoscopy

Here are the five most-read articles on Becker's ASC Review from Oct. 8-16: 

COVID-19-related screening delays could result in an 11.9 percent increase in colorectal cancer mortality across the globe, according to research presented at United European Gastroenterology Week Virtual 2020.

Here are six updates from gastroenterology companies and practices from the past week:

Middletown, Conn.-based Middlesex Health recently opened its Center for Digestive Health to unite all its gastrointestinal services, The Middletown Press reports.

Nearly 1 in 12 colonoscopies without an associated intervention ended with an out-of-network claim, according to a new study published in the Annals of Internal Medicine.

The University of Minnesota in Minneapolis launched a new clinical trial that will use CRISPR genetic engineering to treat metastatic gastrointestinal solid tumor cancer, according to an Oct. 12 press release.

Takeda has entered into a $1.04 billion licensing agreement with Arrowhead Pharmaceuticals around its phase 2 therapy ARO-AAT, which was designed to treat alpha-1 antitrypsin-associated liver disease.

Here are the five most-read Becker's ASC Review articles for gastroenterologists the week of Oct. 5-9:

Independent gastroenterology practice Charleston (S.C.) GI opened an endoscopy center in Summerville, S.C., according to local media outlet Live 5 News.

Nearly 90 percent of U.S. gastroenterologists are open to leveraging artificial intelligence to improve colonoscopies, according to a study published in Endoscopy International Open.